| AFM | Atomic force microscopy |
| CRC | Colorectal cancer |
| ECM | Extracellular matrix |
| EMT | Epithelial to mesenchymal transition |
| ER | Estrogen receptor |
| FISH | Fluorescence in situ hybridization |
| HER-2 | Human epidermal growth factor receptor-2 |
| HIF | Hypoxia inducible factor |
| HSCCa | Hypopharyngeal squamous cell carcinoma |
| IC50 | Half-maximal inhibitory concentration |
| IDC | Invasive ductal carcinoma |
| IGF | Insulin growth factor |
| IL-6 | Interleukin 6 |
| KPC | Kras(G12D) p53(R172H)Pdx1 |
| LINC | Linker of nucleoskeleton and cytoskeleton |
| MAPK | Mitogen activated protein kinase |
| MMP-9 | Matrix metalloproteinase-9 |
| NSCLC | Non-small cell lung cancer |
| OS | Overall survival |
| HSCC | Hypopharyngeal squamous cell carcinoma |
| OV | Ovarian cancer |
| PanIN | Pancreatic intraepithelial neoplasia |
| PDAC | Pancreatic ductal adenocarcinoma |
| PR | Progesterone receptor |
| PSA | Prostate-specific antigen |
| RFS | Remission-free survival |
| SCID | Severe combined immunodeficient mice |
| SCLC | Small cell lung cancer |
| shRNA | Short-hairpin RNA |
| SNP | Single nucleotide polymorphisms |
| TGF-β | Transforming growth factor β |
| TNBC | Triple negative breast cancer |